Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs574293 | chr10:99699426 | G/A | 5.45E-5 | 173 | 24.52 | 27.33 | 19.03 | KM Plot |
PCPG | rs5743437 | chr8:6733868 | T/C | 1.34E-6 | 172 | 10.73 | 19 | 27.3 | KM Plot |
PCPG | rs5743439 | chr8:6733800 | C/A | 1.16E-5 | 171 | 13.27 | 19.3 | 27.27 | KM Plot |
PCPG | rs5743440 | chr8:6733773 | C/T | 1.16E-5 | 171 | 13.27 | 19.3 | 27.27 | KM Plot |
PCPG | rs5743464 | chr8:6732058 | T/A | 7.25E-6 | 177 | 13.27 | 18.7 | 27.33 | KM Plot |
PCPG | rs5743465 | chr8:6732057 | G/C | 7.25E-6 | 177 | 13.27 | 18.7 | 27.33 | KM Plot |
PCPG | rs57486514 | chr3:108535106 | C/CA | 6.34E-5 | 174 | 25.47 | 20.3 | 22.7 | KM Plot |
PCPG | rs57492102 | chr16:89975572 | A/G | 0.00018 | 174 | 25.87 | 20.28 | 3.17 | KM Plot |
PCPG | rs57495703 | chr3:39240015 | C/T | 4.36E-7 | 174 | 25.17 | 25.53 | 21.98 | KM Plot |
PCPG | rs57505611 | chr16:89587579 | C/T | 0.000269 | 177 | 26.78 | 25.67 | 19.25 | KM Plot |
PCPG | rs5752263 | chr22:21276601 | C/G | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs5752272 | chr22:21286562 | C/A | 0.000138 | 175 | 12.93 | 31.9 | 25.47 | KM Plot |
PCPG | rs5752273 | chr22:21287643 | A/G | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs5752274 | chr22:21287911 | A/G | 0.000107 | 176 | 12.57 | 31.68 | 25 | KM Plot |
PCPG | rs5752284 | chr22:21292744 | C/T | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |